This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
O1‐01‐05: [18F]FLUTEMETAMOL AMYLOID PET IN SYMPTOMATIC ALZHEIMER'S DISEASE (AD) AND PATHOLOGICALLY PRECLINICAL AD (P‐PREAD) IN COMPARISON TO NON‐AD CONTROLS: IMPACT OF CEREBRAL AMYLOID ANGIOPATHY. (1st July 2014)
Record Type:
Journal Article
Title:
O1‐01‐05: [18F]FLUTEMETAMOL AMYLOID PET IN SYMPTOMATIC ALZHEIMER'S DISEASE (AD) AND PATHOLOGICALLY PRECLINICAL AD (P‐PREAD) IN COMPARISON TO NON‐AD CONTROLS: IMPACT OF CEREBRAL AMYLOID ANGIOPATHY. (1st July 2014)
Main Title:
O1‐01‐05: [18F]FLUTEMETAMOL AMYLOID PET IN SYMPTOMATIC ALZHEIMER'S DISEASE (AD) AND PATHOLOGICALLY PRECLINICAL AD (P‐PREAD) IN COMPARISON TO NON‐AD CONTROLS: IMPACT OF CEREBRAL AMYLOID ANGIOPATHY